Clinical trial
Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome
NCT00002479 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00002479 |
|---|---|
| Title | Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome |
| Official title | Phase II Trial of Tretinoin (TRA) in Patients With Mycosis Fungoides/Sezary Syndrome |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | tretinoin |
| Start date | Oct 1, 1991 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Aug 23, 2004 |
| Last update posted | May 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: